EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Evaluation of Potential Drug-Drug Interactions Caused by Antibacterial and Antifungal Drugs in the Intensive Care Unit: A Retrospective Cross-Sectional Study

Şeyda Benligil, Eren Demirpolat, Ayşegül Ulu Kılıç, Kürşat Gündoğan

Journal of Clinical Practice and Research · 2024

DOI: 10.14744/cpr.2023.02996 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Clinical Practice and Research, 2024. Verfasst von Şeyda Benligil und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Erciyes University Faculty of Pharmacy, Kayseri, Türkiye. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Antimicrobial drugs are frequently used in the intensive care unit (ICU) and may cause drug-drug interactions (DDIs) which change treatment outcomes. This study aims to determine the frequency of potential DDIs (pDDIs) caused by antimicrobial drugs in the ICU, according to two databases, address the differences between these two databases, discuss the clinical significance of pDDIs and investigate their relationship with clinical outcomes. Materials and Methods: This study was designed as a 1-year retrospective cross-sectional study. Patients over the age of 18 who used antimicrobials for at least 72 hours were included. pDDIs between other drugs and antimicrobials were checked using the "drug interactions" modules of the Lexicomp and Micromedex databases. Data were collected from the hospital's records by a clinical pharmacist.

Results

A total of 393 drug profiles were evaluated for 100 patients, of which 84.2% were antibacterial drugs. According to at least one database, 88% of patients had pDDIs. Of these, 62.4% were classified as major according to at least one database. Only 27.3% of pDDIs had the same level of interaction in both databases. Common pDDIs posed risks such as additive nephrotoxicity, excessive sedation, respiratory depression and QT interval prolongation. Conclusion: pDDIs should be checked not only by one database but by multiple databases, coupled with the input of an experienced clinical pharmacist.

Schlagwörter

Stichwörter der Autor:innen

Antibacterial drugantifungal drugclinical pharmacydrug-drug interactionsintensive care

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Erciyes University Faculty of Pharmacy, Kayseri, Türkiye.
  • Department of Pharmacology, Erciyes University Faculty of Pharmacy, Kayseri, Türkiye.
  • Department of Infectious Disease and Clinical Microbiology, Erciyes University Faculty of Medicine, Kayseri, Türkiye.
  • Division of Medical Intensive Care, Department of Internal Medicine, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.

Zitieren

APA

Benligil, Ş., Demirpolat, E., Ulu Kılıç, A., & Gündoğan, K. (2024). Evaluation of Potential Drug-Drug Interactions Caused by Antibacterial and Antifungal Drugs in the Intensive Care Unit: A Retrospective Cross-Sectional Study. Journal of Clinical Practice and Research. https://doi.org/10.14744/cpr.2023.02996

Vancouver

Benligil Ş, Demirpolat E, Ulu Kılıç A, Gündoğan K. Evaluation of Potential Drug-Drug Interactions Caused by Antibacterial and Antifungal Drugs in the Intensive Care Unit: A Retrospective Cross-Sectional Study. Journal of Clinical Practice and Research. 2024. doi:10.14744/cpr.2023.02996

BibTeX
@article{Benligil2024,
  author = {Benligil, Şeyda and Demirpolat, Eren and Ulu Kılıç, Ayşegül and Gündoğan, Kürşat},
  title = {Evaluation of Potential Drug-Drug Interactions Caused by Antibacterial and Antifungal Drugs in the Intensive Care Unit: A Retrospective Cross-Sectional Study},
  journal = {Journal of Clinical Practice and Research},
  year = {2024},
  doi = {10.14744/cpr.2023.02996}
}
Kostenlos starten →